We have compared the mitogenic activity and reactivity in receptor binding assays of somatomedin A and multiplication-stimulating activity (MSA), two acid-soluble polypeptides of molecular weight 7-10000 that possess weak intrinsic insulin-like metabolic activity. Somatomedin A was purified to homogeneity from human plasma, and MSA was purified to homogeneity from the conditioned culture media of a cell line, BRL 3A, derived from rat liver. The two peptides stimulated DNA synthesis in chick embryo fibroblasts 3 -4-fold and have superimposable doseresponse curves. Addition of either peptide to chick embryo fibroblasts plated in serum-free medium increased the cell number by 150 in 4 days, compared with an increase of 25 % in control cultures receiving no additions. The two peptides also stimulated DNA synthesis in human fibroblasts in culture 3 -4-fold.Specific receptors for MSA and/or somatomedin A could be demonstrated in intact cells or membranes from chick embryo fibroblasts, human fibroblasts, human placenta, rat liver, and the BRL 3A2 cell line, a subclone of the line that produces MSA. Unlabeled MSA and somatomedin A inhibited the binding of '251-labeled MSA and '251-labeled somatomedin A to each of these receptors with comparable potency. In chick embryo fibroblasts, human fibroblasts, and human placental membranes, the binding of both radioactive ligands also was inhibited by insulin, consistent with the interpretation that lz5I-1abeled MSA and '251-labeled somatomedin A were binding to the same receptor. By contrast, in the BRL 3A2 cell line, insulin inhibited the binding of '251-labeled somatomedin A, but not the binding of '251-labeled MSA, suggesting that the two labeled peptides were binding to different receptors in this cell line. Moreover, '251-labeled MSA, but not '251-labeled somatomedin A, bound specifically to rat liver plasma membranes. These results indicate that human somatomedin A and rat MSA are closely related, but not identical, peptides. They have similar mitogenic activity for cultured fibroblasts, and cross-react with specific cell receptors with comparable potency. The two radioactively labeled peptides, however, can be distinguished by certain cell surface receptors for somatomedin-like peptides.The growth-promoting actions of growth hormone on its target tissues are thought to be mediated by substances in plasma that have been designated somatomedins [ 11. Several growth hormone-dependent polypeptides with properties of somatomedins have Abhreviarions.